Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
0.8181 USD | -4.52% | -9.60% | -29.47% |
Business Summary
Number of employees: 68
Sales per Business
USD in Million | 2022 | Weight | 2023 | Weight | Delta |
---|---|---|---|---|---|
Genetic Diagnostic Testing
100.0
%
| 1 | 100.0 % | 1 | 100.0 % | +69.00% |
Sales per region
USD in Million | 2022 | Weight | 2023 | Weight | Delta |
---|---|---|---|---|---|
Germany
100.0
%
| 1 | 100.0 % | 1 | 100.0 % | +69.00% |
Managers
Managers | Title | Age | Since |
---|---|---|---|
Guido Baechler
CEO | Chief Executive Officer | 59 | 30/06/21 |
William Caragol
DFI | Director of Finance/CFO | 58 | 30/06/21 |
Corinna Gorges
CTO | Chief Tech/Sci/R&D Officer | - | 31/10/21 |
Chief Tech/Sci/R&D Officer | - | 02/08/22 | |
Moritz Eidens
CTO | Chief Tech/Sci/R&D Officer | 41 | - |
Stefan Erlach
HRO | Human Resources Officer | - | - |
Amy Levin
LAW | General Counsel | - | 28/11/22 |
Jane Edwards
PRN | Corporate Officer/Principal | - | 13/06/22 |
Steve Quinn
PRN | Corporate Officer/Principal | - | 26/01/22 |
Philipp Freese
PRN | Corporate Officer/Principal | 42 | 31/01/15 |
Members of the board
Members of the board | Title | Age | Since |
---|---|---|---|
Gregory Tibbitts
BRD | Director/Board Member | 57 | 13/12/22 |
Heiner Dreismann
CHM | Chairman | 69 | 13/12/22 |
Director/Board Member | 66 | 31/10/21 | |
Guido Baechler
CEO | Chief Executive Officer | 59 | 30/06/21 |
Moritz Eidens
CTO | Chief Tech/Sci/R&D Officer | 41 | - |
Nicole Holden
BRD | Director/Board Member | 51 | 31/10/21 |
Alberto Libanori
BRD | Director/Board Member | 35 | 31/10/21 |
Share class
Vote | Quantity | Free-Float | Company-owned shares | Total Float | |
---|---|---|---|---|---|
Stock A | 1 | 21,886,575 | 17,151,888 ( 78.37 %) | 0 | 78.37 % |
Company contact information
Mainz Biomed NV
Sirius Gutenberg Park Robert Koch Strasse 50
55129, Mainz
+49 6131 554 2860
http://mainzbiomed.comSector
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
-29.47% | 17.91M | |
-17.89% | 8.25B | |
+39.20% | 3.58B | |
-39.11% | 2.46B | |
-8.06% | 2.46B | |
-7.35% | 2.38B | |
-19.01% | 1.55B | |
-40.66% | 1.21B | |
+7.56% | 1.11B | |
-15.34% | 1.03B |
- Stock Market
- Equities
- MYNZ Stock
- Company Mainz Biomed N.V.